ArticleJournal of translational medicine2024

DB-1314, a novel DLL3-targeting ADC with DNA topoisomerase I inhibitor, exhibits promising safety profile and therapeutic efficacy in preclinical small cell lung cancer models.

Shengchao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.